Trial Profile
Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt)and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 21 May 2015 New trial record